Sequential neuroradiological and neurophysiological studies in a Japanese girl with merosin-deficient congenital muscular dystrophy

Brain and Development

Volumn 33, Issue 2, 2011, Pages 140-144

  Fujii, Yuji ^a   Sugiura, Chitose ^a   Fukuda, Chisako ^a   Maegaki, Yoshihiro ^a   Ohno, Kousaku ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Demyelination; Dysmyelination; Laminin 2; Merosin deficient congenital muscular dystrophy

Indexed keywords

CHOLINE; CREATINE KINASE; CREATININE; LAMININ ALPHA2; N ACETYLASPARTIC ACID;

ARTICLE; CAPSULA INTERNA; CASE REPORT; CHILD; CONTROLLED STUDY; CORPUS CALLOSUM; CREATINE KINASE BLOOD LEVEL; DIFFUSION WEIGHTED IMAGING; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FRONTAL LOBE; HUMAN; INFANTILE HYPOTONIA; JAPANESE; MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY; METABOLITE; MOTOR NERVE CONDUCTION; MOTOR PERFORMANCE; MUSCLE ACTION POTENTIAL; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; NEUROIMAGING; NEUROPHYSIOLOGY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL LOBE; PROTEIN EXPRESSION; RESPIRATORY FAILURE; SCHOOL CHILD; SENSORY NERVE CONDUCTION; WHITE MATTER;

ANIMALS; BRAIN; CHILD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MUSCULAR DYSTROPHIES; TIME FACTORS;

EID: 78751634482     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.02.003     Document Type: Article

References (18)

1. Pegoraro E., Marks H., Garcia C.A., Crawford T., Mancias P., Connolly A.M., et al. Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 1998, 51:101-110.
2. Tome F.M., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B. Et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci 1994, 317:351-357.
3. Gilhuis H.J., ten Donkelaar H.J., Tanke R.B., Vingerhoets D.M., Zwarts M.J., Verrips A., et al. Nonmuscular involvement in merosin-negative congenital muscular dystrophy. Pediatr Neurol 2002, 26:30-36.
4. Mercuri E., Muntoni F., Berardinelli A., Pennock J., Sewry C., Philpot J., et al. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropediatrics 1995, 26:3-7.
5. Colognato H., Yurchenco P.D. Form and function: the laminin family of heterotrimers. Dev Dyn 2000, 218:213-234.
6. Villanova M., Malandrini A., Sabatelli P., Sewry C.A., Toti P., Torelli S., et al. Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study. Acta Neuropathol 1997, 94:567-571.
7. Buttery P.C., ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 1999, 14:199-212.
8. Caro P.A., Scavina M., Hoffman E., Pegoraro E., Marks H.G. MR imaging findings in children with merosin-deficient congenital muscular dystrophy. Am J Neuroradiol 1999, 20:324-326.
9. Trevisan C.P., Martinello F., Feruzza E., Fanin M., Chevally M., Tome F.M. Brain alterations in the classical form of congenital muscular dystrophy: clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle. Childs Nerv Syst 1996, 12:604-610.
10. Taratuto A.L., Lubieniecki F., Diaz D., Schultz M., Ruggieri V., Saccoliti M., et al. Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study. Neromus Disord 1999, 9:86-94.
11. Claudia C., Leandro T., Maria G., Lucio G., Maria B., Mary S., et al. Merosin-deficient congenital muscular dystrophy(CMD):a study of 25 Brazilian patients using MRI. Pediatr Radiol 2005, 35:572-579.
12. Brockmann K., Dechent P., Bonnemann C., Schreiber G., Frahm J., Hanefeld F. Quanitative proton MRS of cerebral metabolites in laminin α2 chain deficiency. Brain Dev 2007, 29:357-364.
13. Villanova M., Malandrini A., Toti P., Salvestroni R., Six J., Martinn J.J., et al. Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol 1996, 28:1-4.
14. Shorer Z., Philpot J., Muntoni F., Sewry C., Dubowitz V. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol 1995, 10:472-475.
15. Mercuri E., Pennock J., Goodwin F., Sewry C., Cowan F., Dubowitz L., et al. Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy. Neuromus Disord 1996, 6:425-429.
16. Nakagawa M., Miyagoe-Suzuki Y., Ikezoe K., Miyata Y., Nonaka I., Harii K., et al. Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant(dy3K/dy3K)mice. Glia 2001, 35:101-110.
17. Xu H., Christmas P., Wu X.R., Wever U.M., Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 1994, 91:5572-5576.
18. Parano E., Uncine A., De Vivo D.C., Lovelace R.E. Electrophysiologic correlates of peripheral nervous system maturation in infancy and childhood. J Child Neurol 1993, 8:336-338.